Amazon Enters $3 Trillion Club as $8 Billion Lantheus Deal, $5.7 Billion Integer Buyout and $3.8 Billion Atkore Acquisition Lead Markets  

Mumbai, Aug 4: Wall Street witnessed a broad wave of corporate activity on August 3, led by Amazon crossing the $3 trillion market capitalisation milestone after robust quarterly earnings. The session also featured major merger and acquisition announcements, strong earnings from financial, healthcare and travel companies, fresh IPO activity, strategic partnerships, convertible debt offerings and capital allocation updates, while investors closely tracked SpaceX’s upcoming first earnings report and developments across technology, biotech and financial stocks. 

Amazon Tops $3 Trillion Market Cap as Shares Hit Record High After Strong Q2 Results 

Amazon’s market value surpassed $3 trillion for the first time on August 3 as its shares climbed about 4.8% to a record high following stronger-than-expected second-quarter earnings. The company reported adjusted EPS of $1.97, beating estimates of $1.82, while revenue rose to $200.61 billion, ahead of the expected $196.47 billion.  

Amazon Web Services generated $42.2 billion in revenue, topping forecasts of $40.54 billion, driven by robust AI-related cloud demand. CEO Andy Jassy also raised the company’s 2026 capital expenditure forecast to $220 billion, from $200 billion, citing surging AI infrastructure demand and stating capacity is expected to remain constrained through 2028. 

SpaceX Faces Crucial First Earnings Test After Stock Slumps More Than 50% From Post-IPO Peak 

SpaceX is set to report its first earnings as a public company on August 4, with investor sentiment under pressure after the stock fell more than 50% from its post-IPO high, erasing over $500 billion in market value. Investors will closely watch progress on Starship, AI infrastructure, data centre expansion and cash burn. The company’s valuation of about $1.4 trillion is supported largely by long-term growth expectations rather than current financial metrics.  

Analysts also expect updates on orbital AI computing, semiconductor availability, regulatory approvals and the pending $60 billion acquisition of AI coding startup Cursor, while expiring insider lock-ups and capital spending remain key concerns. 

Marriott Q2: $3.19 EPS Beat Overshadowed by $7.07 Billion Revenue Miss, Shares Drop 7% 

Marriott International reported mixed second-quarter results, with adjusted EPS rising 20% year-on-year to $3.19, beating analysts’ estimates of $3.05. However, revenue increased 4.8% to $7.07 billion, missing the consensus estimate of $7.17 billion, while Q3 adjusted EPS guidance of $2.74–$2.82 came in below market expectations, sending the stock down around 7% in trading. Worldwide RevPAR grew 3.4%, supported by a 3.5% increase in average daily rates, although occupancy slipped 10 basis points to 71.6%. U.S. and Canada RevPAR rose 5%, with Luxury RevPAR up over 9% and select-service RevPAR increasing more than 4%.  

International RevPAR declined 0.5% due to a 43% drop in the Middle East, while Europe (+4.2%), APEC (+5.3%), Greater China (+3.2%), and the Caribbean and Latin America (+3.0%) recorded growth. Gross fee revenue climbed 13% to $1.578 billion, including a 19% rise in franchise fees to $1.023 billion, while adjusted EBITDA increased 13% to $1.592 billion. Marriott reported 4.5% net room growth and a record pipeline of 629,000 rooms, including 279,000 under construction. The company raised its FY26 adjusted EPS outlook to $11.64–$11.81 and reaffirmed 3.0%–3.5% worldwide RevPAR growth, while forecasting Q3 RevPAR growth of 3.5%–4.0% and adjusted EBITDA growth of 7%–9% despite continued weakness in the Middle East. 

Loews Shares Rise 0.22% After Q2 EPS Climbs to $2.16 and Revenue Reaches $4.73 Billion 

Loews Corporation reported stronger second-quarter results, with net income rising to $444 million from $391 million a year earlier, while diluted EPS increased 15.5% to $2.16 from $1.87. Revenue grew 3.9% to $4.73 billion, supported by its insurance, pipeline, and hospitality businesses. Loews shares gained 0.22% to $116.26, after trading between an intraday high of $117.50 and a low of $115.35.  

Insurance subsidiary CNA Financial generated $3.83 billion in revenue, while Boardwalk Pipelines and Loews Hotels posted net income of $100 million and $48 million, respectively. Book value per share increased to $93.52, with the company ending the quarter with $4.4 billion in cash and investments. 

Tyson Foods Shares Jump 2.5% After Q3 Profit Rises Despite Revenue Miss 

Tyson Foods reported mixed third-quarter results, with adjusted EPS increasing to $0.99 from $0.91 a year earlier but missing analysts’ expectations of $1.01. Revenue remained flat at $13.87 billion, below the $14.07 billion consensus estimate, while adjusted operating income rose 8% to $547 million. Despite the revenue miss, Tyson shares gained 2.54% to $59.38, after trading between an intraday high of $59.87 and a low of $54.53. 

 The chicken segment continued to drive growth, with adjusted operating income rising 8.9% to $488 million, while the beef business remained under pressure as revenue fell 3.9% and adjusted losses widened to $138 million. Tyson updated its FY26 revenue growth outlook to 2.5%–3.5% and expects beef segment losses of $500 million–$650 million for the fiscal year. 

Also Read: How to Invest in the US Stocks From India?

MUFG Gains, EchoStar Expands Buyback, CNA Beats Q2 Estimates 

Mitsubishi UFJ Financial Group (NYSE: MUFG) rose 0.14% to $22.48, trading between $22.35 and $22.87, after reporting a 48.2% year-on-year increase in first-quarter net profit to 809.4 billion yen ($5.2 billion). Higher domestic loan spreads, which widened to 1.15% from 0.95%, strong U.S. data centre project finance activity and earnings from its 24.2% stake in Morgan Stanley drove results. 

EchoStar said its Hughes unit filed for Chapter 11 bankruptcy after missing a $1.5 billion bond maturity, while stressing the proceedings are limited to Hughes entities and do not affect the parent company. The company increased its share repurchase authorisation to $5 billion, retained $14–15 billion in cash after reserving $2.4 billion for Boost-related obligations, and highlighted its holding of 261.8 million SpaceX shares. 

CNA Financial (NYSE: CNA) exceeded expectations with Q2 adjusted EPS of $1.19, beating estimates of $1.01 by 18%, while revenue surged 59% to $4.73 billion. The insurer reported $321 million in net income, declared a $0.48-per-share quarterly dividend, and its shares gained 2.5% to $53.78. 

Krystal Biotech, TG Therapeutics and MakeMyTrip Deliver Strong Earnings as Shares React 

Healthcare and travel companies reported mixed but largely upbeat quarterly results on August 3. Krystal Biotech posted Q2 adjusted EPS of $1.79, beating estimates of $1.70 by 5.3%, while revenue increased to $119.2 million from $96.0 million a year earlier, slightly ahead of forecasts. Despite the earnings beat, the stock fell 8.3%, suggesting investors focused on future growth expectations. 

TG Therapeutics reported Q2 revenue of about $240 million, driven by $228 million in U.S. sales of multiple sclerosis drug BRIUMVI, and recorded net income of $7.8 million ($0.05 per share). The company raised its 2026 revenue guidance to $890–905 million following strong demand and encouraging Phase III trial results. 

Meanwhile, MakeMyTrip surged 11.2% after reporting adjusted EPS of $0.53, crushing the $0.22 consensus estimate by 141%. Revenue rose 16.1% year over year to $285.6 million, although it missed estimates by 2%. Constant-currency gross booking value grew 19.9%, supported by strong demand for hotels, buses, cabs and experiences, while cash and equivalents stood at $794 million and the company repurchased $7.8 million of shares during the quarter. 

Atkore Shares Surge 28% on Prysmian’s $3.8 Billion Buyout; Lantheus Gains After Curium’s Up to $8 Billion Acquisition 

M&A activity lifted healthcare and industrial stocks on August 3, with Atkore Inc. and Lantheus Holdings posting strong gains following takeover announcements. Atkore shares surged 28.18% to $93.54, after trading between $93.30 and $93.60, as Prysmian agreed to acquire the electrical products maker in a $3.8 billion all-cash deal. Prysmian will pay $95 per share, representing a 30% premium to Atkore’s previous close of $72.96. The acquisition, expected to close by December 31, 2026, is projected to generate $150 million in annual pre-tax synergies within three years, with the combined company targeting €22 billion in 2025 revenue and €2.7 billion in adjusted EBITDA.  

Separately, Atkore reported strong Q3 results, with adjusted EPS of $1.92 versus estimates of $1.54, revenue rising 8.1% year-over-year to $794.8 million, net income of $65.7 million, Electrical segment revenue of $578.3 million, and adjusted EBITDA of $104.7 million. Meanwhile, Lantheus Holdings rose 2.17% to $101.80, after trading between $101.67 and $102.90, after Curium agreed to acquire the company in a deal worth up to $8 billion. Shareholders will receive $102.50 per share in cash plus contingent value rights of up to $12 per share, valuing the offer at up to $114.50 per share, a 14.9% premium to Lantheus’ previous close, with completion expected in the first half of 2027. 

Integer Shares Rise 2.7%, Bowhead Jumps 10.2% After $5.7 Billion KKR Buyout and $1.2 Billion American Family Deal 

Healthcare dealmaking accelerated on Monday as KKR agreed to acquire Integer Holdings in an all-cash deal valued at approximately $5.7 billion, while American Family Mutual Insurance struck a $1.2 billion agreement to buy Bowhead Specialty Holdings. Under the Integer transaction, KKR will pay $127 per share in cash, representing a 4.78% premium to Integer’s previous closing price, with the deal expected to close by year-end 2026. Integer shares rose 2.69% to $124.86, after trading between an intraday high of $125.57 and a low of $124.16.  

Meanwhile, Bowhead shares surged 10.17% to $33.70, after touching an intraday high of $35.07 and a low of $33.50, as American Family offered $34.00 per share in cash, an 11% premium to Bowhead’s July 31 closing price. The Bowhead acquisition is expected to close before the end of 2026, subject to shareholder and regulatory approvals, with the insurer continuing to operate as a standalone business under the American Family platform. 

Supernus Shares Gain 5.7% as Indivior Merger Creates $2.2 Billion CNS Drug Company 

Supernus Pharmaceuticals and Indivior Pharmaceuticals agreed to an all-stock merger of equals that will create a central nervous system (CNS)-focused company with about $2.2 billion in annual revenue, 11 marketed medicines, and approximately $125 million in annual cost savings. Supernus shares rose 5.65% to $47.15, after trading between an intraday high of $52.50 and a low of $45.84, while Indivior shares declined 4.90% to $38.05, after fluctuating between $41.18 and $37.56.  

Under the agreement, Supernus shareholders will receive 1.5401 Indivior shares for each share held, while Indivior shareholders will receive a $1 billion special cash dividend before closing. The combined company, to be renamed Supernus, Inc., will be led by CEO Jack Khattar, carry about $878 million in net debt, and is expected to close in Q4 2026, subject to regulatory and shareholder approvals. 

Mastercard Shares Edge Higher as It Completes BVNK Acquisition; Yellow.ai to Go Public in $550 Million SPAC Deal 

Mastercard completed its acquisition of BVNK, strengthening its stablecoin and digital payments capabilities as it expands interoperability between traditional payment rails and digital assets. Following the announcement, Mastercard shares rose 0.33% to $574.98, after trading between an intraday high of $583.71 and a low of $570.78. The acquisition enhances Mastercard’s infrastructure for cross-border B2B payments, remittances, payouts, settlement, and treasury flows, enabling financial institutions and enterprises to seamlessly move value across fiat and digital currencies. 

Separately, enterprise AI platform Yellow.ai agreed to go public through a merger with Bluerock Acquisition Corp. in a transaction valuing the company at a pre-money valuation of approximately $300 million and implying a pro forma equity value of about $550 million. The deal is expected to generate more than $200 million in gross proceeds, including about $175 million held in Bluerock’s trust account and $30 million in committed PIPE financing. Yellow.ai, which serves 650 enterprise customers across 85 countries, reported $34 million in revenue last fiscal year and processes 16 billion conversations annually across 135 languages. The transaction is expected to close in the second half of 2026, subject to shareholder approval. 

Also Read: How to Invest in S&P 500 Stocks Through Index Funds

AstraZeneca Shares Sink 7.4% on Bristol Myers Merger Talks as Liberty Global Completes VodafoneZiggo Buyout 

AstraZeneca shares fell 7.43% after reports that the drugmaker had held early-stage merger discussions with Bristol Myers Squibb on a potential combination that could create a pharmaceutical giant worth nearly $400 billion. Meanwhile, Bristol Myers Squibb shares gained around 6% in premarket trading. Neither company confirmed the discussions, and sources indicated the talks may not lead to a transaction. Analysts questioned the strategic rationale, while experts warned a deal could face significant antitrust scrutiny due to the companies’ overlapping oncology portfolios. Before Monday’s session, AstraZeneca’s market capitalization stood at $264 billion, compared with about $133 billion for Bristol Myers Squibb. 

Separately, Liberty Global completed its acquisition of Vodafone’s remaining 50% stake in VodafoneZiggo, creating Ziggo Group, a Benelux telecom company serving 13 million customers with €6.6 billion in annual revenue. Vodafone received approximately €1.0 billion in cash and a 10% stake in Ziggo Group, while Liberty Global retained the remaining 90%. The company plans to list Ziggo Group in Amsterdam in 2027 after spinning off its stake to shareholders, alongside ongoing €1.2–€1.4 billion in asset disposals aimed at reducing debt. 

BSF Shares Jump 41% on U.S. Leather JV as Danone, MDWerks and Chiron Announce Strategic Partnerships 

BSF Enterprise shares surged 41.18% after the company unveiled plans for a 50:50 joint venture with U.S.-based IMPOSTER to commercialise its lab-grown T-Rex Leather in the American luxury market. IMPOSTER is expected to invest $500,000-$1 million from a planned $3.5 million capital raise, while BSF will contribute its technology and material supply without investing cash. The company expects to generate 25%-35% gross margins on material transfers, 3%-7% royalties on net sales, and 50% of venture profits, with product launches planned from the Hampton Classic Horse Show through New York Fashion Week. 

Elsewhere, Danone shares gained 0.41% to €67.80, after trading between €67.14 and €68.08, as it completed a 50:50 dairy joint venture with Arcor in Argentina by acquiring the remaining 51% stake in Mastellone Hermanos. MDWerks signed a non-binding LOI for a proposed joint venture between RF Specialties (51%) and Rex Lumber (49%) to commercialise radio frequency-based lumber technologies. Macquarie Group shares rose 0.83% to A$255.20, after touching an intraday high of A$255.20 and low of A$251.02, as Macquarie Capital partnered with Chiron Energy in a 51:49 renewable energy platform targeting 1 GW of solar capacity, 500 MW of battery storage, and €2.5 billion in investments by 2035, supported by 115 MW of operating solar assets, 300 MW of ready-to-build projects, 250 MW of late-stage solar developments, and a 700 MW BESS pipeline. 

Strategic Partnerships Drive Gains for Mercury Systems, Shoals Technologies and GameSquare Shares 

Mercury Systems shares climbed 9.37% to $106.20, after trading between an intraday high of $106.66 and low of $99.52, following its strategic partnership with Palantir Technologies to automate material planning and factory operations for U.S. defense manufacturing. Mercury will deploy Palantir Foundry to create a digital twin of its operations, streamline supply-chain planning, and reduce manual workloads under the U.S. Government’s Tradewind Prototype Agreement, supporting faster production of critical defense systems. 

Elsewhere, Shoals Technologies shares rose 7.27% to $9.38, after moving between $8.72 and $9.48, after signing a memorandum of understanding with TerraFlow Energy to support the deployment of up to 5 GW annually of long-duration energy storage projects. The partnership combines TerraFlow’s vanadium flow battery platform with Shoals’ PowerHub™ and AirLink™ power distribution solutions for utility-scale projects and AI data centres. 

Meanwhile, GameSquare Holdings shares gained 7.30% to $0.36, after trading between $0.34 and $0.37, after announcing a sales partnership with MEGA Advanced. Under the agreement, GameSquare will exclusively commercialise sponsorship opportunities for the Esports Awards and The Mobies, expanding its premium gaming intellectual property portfolio and strengthening its ability to connect global brands with gaming, creator, and esports audiences. 

BK Technologies, Nexera and WaterPure Advance Strategic Licensing Deals as Shares Gain Up to 58.6% 

BK Technologies shares were little changed, edging 0.14% lower to $79.89, after trading between an intraday high of $80.81 and low of $78.97, following a strategic licensing and collaboration agreement with Tango Tango. Under the deal, Tango Tango will receive an initial three-year licence, renewable annually, for BK’s patented InteropONE technology, expanding its reach across more than 1,500 public safety agencies, 35,000 active users, and 49 U.S. states, while creating new recurring software revenue opportunities. 

Meanwhile, Nexera Technologies shares surged 12.75% to $3.98, after moving between $3.05 and $5.28, after signing a letter of intent with Nebo Holdings for the exclusive worldwide distribution rights to the Preempt OSINT darknet intelligence platform for data centre operators. The proposed agreement includes a 36-month licence term, extendable by 24 months, and remains subject to technical validation, due diligence and regulatory approvals. 

Elsewhere, WaterPure International shares jumped 58.60% to $0.0059, after touching an intraday high of $0.0068 and low of $0.0043, after executing a non-exclusive Research License Agreement with NASA to evaluate advanced membrane and filtration technologies for industrial water applications across agriculture, HVAC systems, data centres and U.S. military installations. Any commercial deployment would require a separate licensing agreement with NASA. 

Biotech IPOs Gather Pace as Latigo, BlossomHill Launch Offerings; Robinhood Targets $200 Million, Fund Listing 

The U.S. IPO market remained active on Monday as Latigo Biotherapeutics, BlossomHill Therapeutics, and Robinhood Ventures Fund II launched public offerings, reflecting renewed investor appetite for biotech and private-market investments. Latigo Biotherapeutics is targeting a $1.08 billion valuation and plans to raise $288 million by offering 16 million shares priced between $16 and $18 each. The company is developing LTG-001, a non-opioid oral pain treatment for moderate-to-severe acute pain, and plans to list on Nasdaq under the ticker LTGO. 

Meanwhile, BlossomHill Therapeutics aims for a $494.38 million valuation, seeking to raise $132.8 million through the sale of 7.8 million shares priced between $15 and $17 each. Founded in 2020, the biotech focuses on small-molecule therapies for oncology and autoimmune diseases and intends to trade on Nasdaq under the symbol BLSM. 

Separately, Robinhood Ventures Fund II (RVII) launched an IPO targeting up to $200 million by offering 8 million shares at $25 per share, including 400,000 shares owned by Robinhood. The fund will invest in early- and growth-stage private companies, particularly Y Combinator startups. The IPO window closes on August 12, with shares expected to list on the New York Stock Exchange under the ticker RVII. 

Additionally, IPO momentum broadened beyond biotech. Five SPACs priced and began trading on Nasdaq: East West Ave Acquisition ($100 million), Wilco 63 ($230 million), Futurewave Acquisition ($86.25 million), Willow Lane Acquisition Corp. II ($143.75 million) and GX Acquisition III ($200 million). Several traditional IPOs are also scheduled this week, including Londian Wason (targeting a $1.7 billion valuation), Attovia Therapeutics ($212.5 million, Aug. 4), Braveheart Bio ($318.8 million, Aug. 5), River City Bank ($140.3 million, Aug. 5) and Vogenx ($81.3 million, Aug. 5). Separately, Flutter Entertainment completed the cancellation of its London Stock Exchange secondary listing, leaving its shares exclusively listed on the NYSE. 

Also Read : US Stock Market Timings

GameStop Shares Sink 13.4% as $1.4 Billion Debt Exchange Unveiled; Procore Seeks $750 Million and Southern Company Raises $2.15 Billion via Convertible Notes 

Convertible debt activity intensified on August 3 as GameStop, Procore Technologies and Southern Company announced major financing transactions. GameStop agreed to exchange $1.4 billion of convertible senior notes, $400 million of 0.00% notes due 2030 and $1.0 billion due 2032, for Class A common stock in privately negotiated deals, eliminating $1.4 billion of debt without raising cash. About $1.1 billion of 2030 notes and $1.7 billion of 2032 notes will remain outstanding. The exchange is expected to close around September 23. GameStop shares tumbled 13.44% to $18.80, after trading between $18.56 and $20.50.  

Meanwhile, Procore plans to issue $750 million of convertible senior notes due 2031, with an option for an additional $112.5 million, to help fund its DroneDeploy acquisition, capped-call transactions and a $175 million share repurchase. Procore shares slipped 0.17% to $54.68. Separately, Southern Company launched $2.15 billion of convertible senior notes—$650 million due 2027 and $1.5 billion due 2029—with potential upsizing of $322.5 million, using proceeds to refinance existing convertible notes, repay short-term debt and support general corporate purposes. Southern shares declined 0.97% to $93.60. 

Strategy Resumes Bitcoin Sales While Agnico Eagle Highlights Buyback and Dividend Ahead of Mining Forum 

Corporate capital allocation remained in focus as Strategy resumed Bitcoin sales and Agnico Eagle Mines highlighted shareholder returns ahead of the Diggers & Dealers Mining Forum. Strategy sold 1,638 Bitcoin for $104.73 million, at an average price of $63,957 per coin, reducing its holdings to 842,138 BTC after a four-week pause. The proceeds funded $52.4 million in preferred stock dividends and $52.3 million in STRC share repurchases. The company also raised $290.6 million through an at-the-market share sale, allocating $250 million to its USD Reserve, which now totals $4.0 billion.  

Meanwhile, Agnico Eagle reaffirmed its $0.45 per share quarterly dividend after completing a $377.48 million share buyback covering 2.11 million shares (0.42%). The gold miner also reported Q2 net income of $1.60 billion and first-half net income of $3.30 billion, while maintaining 2026 production guidance at the lower end of its 3.3-3.5 million-ounce target range ahead of its investor presentation. 

Overall, August 3 highlighted resilient corporate activity despite mixed market sentiment, with strong earnings, multi-billion-dollar acquisitions, capital-raising initiatives and strategic partnerships shaping investor focus. As companies continue investing heavily in AI, cloud infrastructure and healthcare, markets remain closely attuned to execution, guidance and broader macroeconomic developments. 

Source 

• https://www.nasdaq.com/ 

• spglobal.com/spdji/en/indices/equity/sp-500/ 

• https://www.dowjones.com/ 

• https://www.spglobal.com/spdji/en/indices/equity/dow-jones-industrial-average/ 

• https://www.spglobal.com/spdji/en/indices/equity/sp-500/ 

• https://www.nasdaq.com/market-activity/index/comp 

• https://www.nasdaq.com/market-activity/quotes/nasdaq-ndx-index 

• https://www.spglobal.com/spdji/en/indices/equity/sp-100/ 

• https://www.lseg.com/en/ftse-russell/indices/russell-us 

• https://www.nyse.com/index 

• https://www.nyse.com/index 

• https://www.spglobal.com/spdji/en/indices/equity/dow-jones-transportation-average/ 

• https://www.spglobal.com/spdji/en/indices/equity/dow-jones-utility-average/ 

• https://www.spglobal.com/spdji/en/indices/equity/dow-jones-composite-average/ 

• https://www.nasdaq.com/market-activity/index/sox 
• https://www.cboe.com/tradable_products/vix/